Dr. Jennifer Rose Gordon, MD

Dr. Gordon practices at Westlake Dermatology & Cosmetic Surgery (Bee Caves Rd) in Austin, Texas.

Dr. Gordon's NPI, 1073748281, was assigned on May 18, 2009. Dr. Gordon graduated from Carver College of Medicine in 2009. Dr. Gordon holds Texas license P5367.

Dr. Gordon's primary practice is Westlake Dermatology & Cosmetic Surgery (Bee Caves Rd), at 8825 Bee Caves Road 2nd Floor, Austin, TX 78746. The practice phone is (512) 328-3376.

Dr. Gordon's primary practice is Westlake Dermatology & Cosmetic Surgery (Bee Caves Rd) in Austin, Texas. The medical group on file is Westlake Dermatology & Cosmetic Surgery. Dmand AI also links Dr. Gordon to 1 more clinical lab and 1 group practice or clinic, each named with a free account. Dr. Gordon's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gordon practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Gordon's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gordon is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Gordon's licenses on file in 2 states: Texas and Arizona.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, itchy rashes and rash among the conditions Dr. Gordon treats.

CMS data shows 1,957 Medicare services from Dr. Gordon across 14 procedure codes in 2024, for 271 Medicare patients. Medicare paid $91,556 for them. Every service was in an office.

CMS counts 271 Medicare patients who saw Dr. Gordon in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gordon's median patient age at 49, with 65% women.

In 2024, Dr. Gordon wrote 279 Medicare Part D claims for 119 patients. 93% of them were for generic drugs. CMS names the drug for 170 of them, across 5 drugs with 11 or more claims each, at $3,067 in total drug cost. In 2023, CMS named 150 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gordon for performance year 2024, reported as part of a group. Dr. Gordon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 727 procedures of removal of skin lesions by Dr. Gordon, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Gordon, published from 2011 to 2019. 2011 was the busiest year, with 2. The most frequent topics are Ambulatory Care Facilities, Botulinum Toxins, Type A and Cholinergic Antagonists. Dr. Gordon has published most often in J Am Acad Dermatol. Dr. Gordon's most frequent co-authors are Ammar Moin Ahmed, MD, Kevin P. Bethke, MD and Ashley Landon Brown, MD.

CMS Open Payments shows 1,188 general payments to Dr. Gordon from 42 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 79% of the total. Galderma Laboratories, L.P. paid the most, $157,692.

Dr. Gordon graduated from Carver College of Medicine in 2009.

Dr. Gordon is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.